Considering the relationship between prognosis and gene expression, two biomarkers associated with GBM, including TREM1 and APOC1, were selected from the twenty candidate biomarkers using lasso-cox dimensionality reduction for further analysis (Figure 3B). The gene discussed is TREM1; the disease is glioblastoma.